Dépêches

Cool Containers, LLC Receives FAA Approval for Temperature Controlled Shipping Container

Dépèche transmise le 18 mai 2011 par Business Wire

Cool Containers, LLC Receives FAA Approval for Temperature Controlled Shipping Container

MARIETTA, Ohio--(BUSINESS WIRE)--The Federal Aviation Administration (FAA) has approved the PharmaPort 360™ temperature controlled shipping container for use in commercial and military air transport. The announcement was made by Lew Rosenblum, CEO of Cool Containers, LLC and U.S. Senator Sherrod Brown (D-OH) following 1½ years of formal testing and review.

“The process gave us a deeper understanding of the role the FAA plays in ensuring that our skies are safe for travel.”

“We are grateful to Senator Sherrod Brown and former Congressman Charlie Wilson for their help in navigating government procedures associated with the FAA regulations for air transport of active cargo,” said Rosenblum. “The process gave us a deeper understanding of the role the FAA plays in ensuring that our skies are safe for travel.”

According to Senator Brown, “Cool Containers is the latest example of an innovative Ohio small business creating new jobs. I was proud to help them through the red tape and get them on the path to job creation and business development. This is further proof that when private and public sectors work together, we can see amazing results.”

Designed for shipment of high value pharmaceuticals the PharmaPort 360™ is configured for standard NAS air cargo pallets. The container maintains internal temperature of 5°C in extreme ambient from 60°C to -40°C in transport mode and a charge (ground) mode to assure safe movement of biologicals for optimum viability. It transitions easily through standard international logistic systems including air, sea and highway for precision temperature controlled service in a self-contained modular unit. The payload weight is 1200 lbs (544 kg).

The PharmaPort™ 360 uses proprietary systems developed by Farrar Scientific, LLC to exceed guidelines World Health Organization criteria for cold chain distribution. In flight, the PharmaPort 360™ operates independently of the aircraft and requires no external system power. It generates no heat or hazardous vapors. A self-contained regenerative heat exchanger avoids HAZMAT costs associated with dry ice and eliminates the need for a refrigerated truck. Between uses the container is recharged by a standard AC power supply before deployment in fixed-based storage, ground, sea or air transport.

A data acquisition system operates during all modes. Control and monitoring technology supports proof-of-performance in compliance with FDA 21 CFR 11. GPS tracking permits retrieval and sharing of system performance en route. OQ/PQ documentation is available.

See www.coolcontainersllc.com.